“Real-World Clinician- and Patient-Reported Outcomes and Treatment Persistence Following Bimekizumab Initiation in Patients With Psoriasis: 6-Month Results from the PPD CorEvitas Psoriasis Registry”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s632, https://doi.org/10.25251/6744kd41.